INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 422m ago
House PTR21m ago
SEC 13F21m ago
Robinhood Chain21m ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

21,638 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
29
BR
Balbirnie Brian RDirector, Director, CEO, 10% Owner
ACCSACCESS Newswire Inc.
Open-market purchase
BUY$26K
3,396 sh
Mar 25, 2026
Page 353 of 541
← PrevNext →
Mar 26, 2026
traded Mar 25, 2026
+1d
SEC Form 4

Evidence

29
BA
Balcom AlexandraChief Financial Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$1.37M
13.7K sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

28
DS
Dhanasekaran SatishDirector, President and CEO
KEYSKeysight Technologies, Inc.
Open-market sale
SELL$500K
1,667 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

28
MJ
Murphy Matthew JDirector, Chairman of the Board and CEO
MRVLMarvell Technology, Inc.
Open-market sale · 10b5-1 plan
SELL$2.96M
30.0K sh
Mar 26, 2026Mar 26, 2026
traded Mar 26, 2026
+0dSEC Form 4

Evidence

28
GA
Ghodoosi ArashPresident, Principal Executive
XIVYXInstitutional Investment Strategy Fund
Open-market purchase
BUY$10
1 sh
Mar 23, 2026Mar 26, 2026
traded Mar 23, 2026
+3dSEC Form 4

Evidence

28
MJ
Morais Silvio JoseDirector
STNEStoneCo Ltd.
Open-market sale
SELL$97K
6,800 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

25
OD
Owens Bradley D.General Counsel
ZANDZGZILLOW GROUP, INC.
Open-market sale · 10b5-1 plan
SELL$384K
8,800 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

23
BA
Balcom AlexandraChief Financial Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$247K
2,599 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

23
BA
Balcom AlexandraChief Financial Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$112K
1,160 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

22
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$272K
19.1K sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

22
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$269K
19.1K sh
Mar 26, 2026Mar 26, 2026
traded Mar 26, 2026
+0dSEC Form 4

Evidence

18
SG
Samuelson Errol GChief Industry Dev. Officer
ZANDZGZILLOW GROUP, INC.
Open-market sale · 10b5-1 plan
SELL$209K
4,734 sh
Mar 26, 2026Mar 26, 2026
traded Mar 26, 2026
+0dSEC Form 4

Evidence

16
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$261K
19.1K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

14
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$29K
5,319 sh
Mar 26, 2026Mar 26, 2026
traded Mar 26, 2026
+0dSEC Form 4

Evidence

14
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$32K
5,492 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

14
BE
Bowe Patrick E.Director
ANDEAndersons, Inc.
Open-market sale · 10b5-1 plan
SELL$1.03M
14.2K sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

14
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$39K
7,098 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

11
WC
Werner Edward CooperChief Financial Officer
FFIVF5, INC.
Open-market sale · 10b5-1 plan
SELL$300K
1,000 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

11
CM
Colendich Katie MarieGC, Corporate Secretary
ASANAsana, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
5,015 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

11
CM
Colendich Katie MarieGC, Corporate Secretary
ASANAsana, Inc.
Open-market sale · 10b5-1 plan
SELL$9,585
1,500 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

8
LR
Low RussellDirector, PRESIDENT AND CEO
ACLSAXCELIS TECHNOLOGIES INC
Open-market sale · 10b5-1 plan
SELL$112K
1,244 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

8
BE
Bowe Patrick E.Director
ANDEAndersons, Inc.
Open-market sale · 10b5-1 plan
SELL$58K
800 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

8
RD
Raben DavidChief Medical Officer
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$104K
5,500 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

4
MA
Misra AmitabhChief Technology Officer
CXMSprinklr, Inc.
Open-market sale · 10b5-1 plan
SELL$243K
41.7K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

56
MP
Menell Richard PeterDirector
SBSWSibanye Stillwater Ltd
Open-market purchase
BUY$29K
2,500 sh
Mar 24, 2026Mar 25, 2026
traded Mar 24, 2026
+1dSEC Form 4

Evidence

50
AJ
Angotti Vincent J.Director, CHIEF EXECUTIVE OFFICER
TLPHTALPHERA, INC.
Open-market purchase
BUY$125K
213.3K sh
Mar 13, 2026Mar 25, 2026
traded Mar 13, 2026
+12dSEC Form 4

Evidence

47
AM
Angel MatthewDirector, CEO and President, 10% Owner
TPSTTempest Therapeutics, Inc.
Open-market purchase
BUY$500K
231.5K sh
Mar 24, 2026Mar 25, 2026
traded Mar 24, 2026
+1dSEC Form 4

Evidence

44
AD
Armstrong Courtney DDirector
VRSNVERISIGN INC/CA
Open-market purchase
BUY$3,980
16 sh
Nov 25, 2025Mar 25, 2026
traded Nov 25, 2025
+120dSEC Form 4

Evidence

44
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.03M
12.6K sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

43
KC
Keyter CharlDirector, Chief Financial Officer
SBSWSibanye Stillwater Ltd
Open-market purchase
BUY$95K
35.0K sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

42
PC
Parker Austin ColbyCFO and Treasurer
KYNKayne Anderson Energy Infrastructure Fund, Inc.
Open-market purchase
BUY$36K
2,500 sh
Mar 25, 2026Mar 25, 2026
traded Mar 25, 2026
+0dSEC Form 4

Evidence

41
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$265K
3,162 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

41
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$634K
7,749 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

41
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$265K
3,162 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

41
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$431K
5,140 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

41
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$634K
7,749 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

39
YR
Yekutiel RonDirector, Chief Executive Officer
KLTRKALTURA INC
Open-market purchase
BUY$50K
40.0K sh
Mar 24, 2026Mar 25, 2026
traded Mar 24, 2026
+1dSEC Form 4

Evidence

39
SN
Serero Liron NetanelaSee remarks
KLTRKALTURA INC
Open-market purchase
BUY$6,400
5,000 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

39
RC
Rotshten ClaireEVP of Finance
KLTRKALTURA INC
Open-market purchase
BUY$13K
10.0K sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence

38
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$238K
2,906 sh
Mar 23, 2026Mar 25, 2026
traded Mar 23, 2026
+2dSEC Form 4

Evidence